Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease.
|Symbol||Name||Price||Market Cap||PE Growth Rate(5Y)||Net Margin||EPS Growth(1Y)||Argus Rating|
|EW||Edwards Lifesciences Corporatio||90.53||N/A||N/A||N/A||N/A||N/A|
BLK, ALL, DHI, INTU, CFG, JPM, TXN, AMGN, ADP, ITW, MSFT, COST, PRU, ABT, GLW, MA, SBUX, LLY, SPGI, NOC, SHW, SYK, HON, EL, CMCSA, WEC, ENB, FAST, HD, ODFL
BLK, GOOGL, CVS, DE, AAPL, JPM, MSFT, COST, ABT, MA, AWK, AMD, ZTS, SPGI, UPS, LHX, KLAC, NVDA, HON, ECL, WEC, LOW, NOW, ADBE, ANTM, SCHW, EQIX, FB, ISRG, AMZN